Japan Neurology Devices Market Opportunities, Industry 2031

Segments - Japan Neurology Devices Market by Type of Devices (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Interventional/Surgical Simulators, Neurothrombectomy Devices, Carotid Artery Stents, and Others], Neurosurgery Devices [Neuroendoscopes, Stereotactic Systems, and Others], Neurostimulation Devices [Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, and Others], and Others), and End Users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

Author : Raksha Sharma

Fact-checked by : Vineet Pandey

Editor : Vishal Golekar

Report Description

Japan Neurology Devices Market Outlook 2031:

The Japan neurology devices market size was valued at USD 784.44 Million in 2022 and is projected to reach USD 1.60 Billion by 2031, expanding at a CAGR of 8.3% during the forecast period 2023 - 2031. Growth of the market is attributed to the increasing neurological diseases, rising investment in neuroscience equipment by private agents, and the growth of R&D in neurotherapies.

Neurological equipment helps in early detection of various neurological diseases to help prevent Alzheimer’s disease, major depression, spinal cord injury, acute ischemic stroke, traumatic brain injury, and other diseases. These devices represent minimally invasive based technology. Neurological devices are usually used in complex neurological cases, such as acute ischemic stroke, and are recommended for minimally invasive treatment. Compared to drug thrombolysis, these devices have potential advantages, such as faster recanalization and lower bleeding risk.

Neurology Devices Market Trends, Drivers, Restraints, and Opportunities

Increasing investment in pharmaceutical and biotechnology industry is anticipated to boost the market during the forecast period.
Rapid growth of the healthcare industry due to increasing geriatric population is the major factors fueling the market during the forecast period.
Growing demand for minimally invasive surgeries and improvement in healthcare infrastructure is projected to drive the market during forecast period.
High cost of neurological treatments and devices is anticipated to restrict the market growth.
Implementations of strict regulations by government on neurological devices act as major challenges that can hamper the market growth during the forecast period.
R&D investment and technological advancement of neurological devices for easy and minimally invasive diagnosis of neurological disorders is expected to offer immense opportunities for the market players.

Scope of Neurology Devices Market Report

The report on the Japan neurology devices market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes	Details
Report Title	Japan Neurology Devices Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast
Base Year	2022
Historic Data	2016–2021
Forecast Period	2023–2031
Segmentation	Type of Devices (Cerebrospinal Fluid Management Devices, Interventional Neurology Devices [Interventional/Surgical Simulators, Neurothrombectomy Devices, Carotid Artery Stents, and Others], Neurosurgery Devices [Neuroendoscopes, Stereotactic Systems, and Others], Neurostimulation Devices [Spinal Cord Stimulation Devices, Deep Brain Stimulation Devices, Sacral Nerve Stimulation Devices, and Others], and Others), and End Users (Hospitals, Ambulatory Surgery Centers, and Neurology Clinics)
Geography	Japan
Report Coverage	Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
Key Players Covered in the Report	Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, and Medtronic PLC

Neurology Devices Market Segment Insights

The sacral nerve stimulation segment is projected to hold a major market share

Based on type of devices, the neurology devices market is fragmented into cerebrospinal fluid management devices, interventional neurology devices, neurosurgery devices, neurostimulation devices, and others.

The sacral nerve stimulation segment is expected to represent a key share of the market during the forecast period owing to increasing neurological diseases, large investment in neuroscience equipment by private agents, and growth of R&D in neurotherapies. These devices are effective in treating bladder problems. Therefore, as the incidence of overactive bladder increases, it is expected that the demand for sacral nerve stimulation devices will grow during the forecast period.

The sacral nerve stimulation device is an effective and safe method for treating patients with stool and urinary dysfunction. Increasing demand for minimally invasive therapies, increasing prevalence of bladder diseases, and introduction of new coatings and engineering strategies are the main factors driving the market.

The hospitals segment is anticipated to expand at a substantial CAGR

Based on end users, the neurology devices market is segregated into hospitals, ambulatory surgery centers, and neurology clinics. The hospital segment accounts for a significant share of the market. Growth of the market is attributed to increasing prevalence of neurological disorders and rapid advancement in neurology devices.

On the other hand, the ambulatory surgery centers segment is anticipated to expand at a rapid pace during the forecast period due to increasing inclination of patients for minimally invasive medical procedures, increasing number of outpatient surgery centers in developed countries, and convenience of programming in these centers, professional clinical staff, increased productivity, and increased safety and efficiency.

Segments

The Japan neurology device market has been segmented on the basis of

Type of Devices

Cerebrospinal Fluid Management Devices
Interventional Neurology Devices
- Interventional/Surgical Simulators
- Neurothrombectomy Devices
- Carotid Artery Stents
- Others
Neurosurgery Devices
- Neuroendoscopes
- Stereotactic Systems
- Others
Neurostimulation Devices
- Spinal Cord Stimulation Devices
- Deep Brain Stimulation Devices
- Sacral Nerve Stimulation Devices
- Other Neurostimulation Devices
Other Types of Devices

End Users

Hospitals
Ambulatory Surgery Centers
Neurology Clinics

Key Players

Stryker Corporation
Abbott Laboratories
Boston Scientific Corporation
B. Braun Melsungen AG
Medtronic PLC

Competitive Landscape

Key players competing in the neurology devices market include Stryker Corporation, Abbott Laboratories, Boston Scientific Corporation, B. Braun Melsungen AG, and Medtronic PLC.

Some of these players are using several market strategies including mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to increase their market shares.

Japan Neurology Devices Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurology Devices Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Neurology Devices Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Neurology Devices Market - Supply Chain
  4.5. Global Neurology Devices Market Forecast
     4.5.1. Neurology Devices Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Neurology Devices Market Size (000â€™ Units) and Y-o-Y Growth
     4.5.3. Neurology Devices Market Absolute $ Opportunity
5. Global Neurology Devices Market Analysis and Forecast by End Users
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by End Users
     5.2.2. Y-o-Y Growth Projections by End Users
  5.3. Neurology Devices Market Size and Volume Forecast by End Users
     5.3.1. Hospitals
     5.3.2. Ambulatory Surgery Centers
     5.3.3. Neurology Clinics
  5.4. Absolute $ Opportunity Assessment by End Users
  5.5. Market Attractiveness/Growth Potential Analysis by End Users
6. Global Neurology Devices Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Neurology Devices Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Neurology Devices Demand Share Forecast, 2019-2026
7. North America Neurology Devices Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Neurology Devices Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Neurology Devices Market Size and Volume Forecast by End Users
     7.4.1. Hospitals
     7.4.2. Ambulatory Surgery Centers
     7.4.3. Neurology Clinics
  7.5. Basis Point Share (BPS) Analysis by End Users
  7.6. Y-o-Y Growth Projections by End Users
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Neurology Devices Demand Share Forecast, 2019-2026
8. Latin America Neurology Devices Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Neurology Devices Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Neurology Devices Market Size and Volume Forecast by End Users
     8.4.1. Hospitals
     8.4.2. Ambulatory Surgery Centers
     8.4.3. Neurology Clinics
  8.5. Basis Point Share (BPS) Analysis by End Users
  8.6. Y-o-Y Growth Projections by End Users
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Neurology Devices Demand Share Forecast, 2019-2026
9. Europe Neurology Devices Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Neurology Devices Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Neurology Devices Market Size and Volume Forecast by End Users
     9.4.1. Hospitals
     9.4.2. Ambulatory Surgery Centers
     9.4.3. Neurology Clinics
  9.5. Basis Point Share (BPS) Analysis by End Users
  9.6. Y-o-Y Growth Projections by End Users
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Neurology Devices Demand Share Forecast, 2019-2026
10. Asia Pacific Neurology Devices Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Neurology Devices Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Neurology Devices Market Size and Volume Forecast by End Users
     10.4.1. Hospitals
     10.4.2. Ambulatory Surgery Centers
     10.4.3. Neurology Clinics
  10.5. Basis Point Share (BPS) Analysis by End Users
  10.6. Y-o-Y Growth Projections by End Users
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Neurology Devices Demand Share Forecast, 2019-2026
11. Middle East & Africa Neurology Devices Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Neurology Devices Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Neurology Devices Market Size and Volume Forecast by End Users
     11.4.1. Hospitals
     11.4.2. Ambulatory Surgery Centers
     11.4.3. Neurology Clinics
  11.5. Basis Point Share (BPS) Analysis by End Users
  11.6. Y-o-Y Growth Projections by End Users
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Neurology Devices Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Neurology Devices Market: Market Share Analysis
  12.2. Neurology Devices Distributors and Customers
  12.3. Neurology Devices Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Stryker Corporation
     12.4.2. Abbott Laboratories
     12.4.3. Boston Scientific Corporation
     12.4.4. B. Braun Melsungen AG
     12.4.5. Medtronic PLC